Compare High Dividend Stocks

High-dividend stocks pay substantial cash per share, making them a strong choice for investors seeking steady, meaningful income from established companies. Unlike high-yield stocks, which focus on payout size relative to share price, high-dividend stocks are defined by the absolute dollar amount paid, often by blue-chip firms, utilities, consumer staples leaders, and other cash-rich businesses with long records of rewarding shareholders.

Whether you’re interested in dividend powerhouses in consumer goods, energy, banking, or healthcare, the high-dividend sector offers stability, income, and the potential for long-term capital appreciation.

Our comparison tool lets you evaluate up to ten high-dividend stocks side by side, analyzing performance trends, payout history, analyst ratings, financial strength, dividends, and more. This list is regularly updated so you can quickly spot the strongest opportunities and focus on companies that consistently deliver substantial income year after year.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
PEP PepsiCo	$149.64 +0.4%	$139.32	$127.60 ▼ $179.73	$203.97B	0.45	7.95 million shs	5.22 million shs
ABBV AbbVie	$210.28 +0.4%	$192.84	$163.81 ▼ $218.66	$370.09B	0.5	5.09 million shs	5.52 million shs
CVX Chevron	$157.90 +1.5%	$151.21	$132.04 ▼ $168.96	$268.79B	0.87	8.17 million shs	9.08 million shs
JNJ Johnson & Johnson	$179.10 +0.1%	$163.48	$140.68 ▼ $181.16	$430.92B	0.41	8.49 million shs	9.52 million shs
KO CocaCola	$70.08 -0.8%	$69.85	$60.62 ▼ $74.38	$304.10B	0.44	12.72 million shs	12.99 million shs
PFE Pfizer	$25.83 +0.3%	$24.70	$20.92 ▼ $30.43	$147.14B	0.52	44.53 million shs	34.54 million shs
PG Procter & Gamble	$158.51 -0.1%	$156.79	$149.91 ▼ $180.43	$371.80B	0.37	7.60 million shs	5.80 million shs
XOM Exxon Mobil	$111.12 +1.7%	$110.24	$97.80 ▼ $126.34	$465.67B	0.53	15.56 million shs	13.58 million shs
RY Royal Bank of Canada	C$190.65 +0.7%	C$180.93	C$151.25 ▼ C$191.22	C$269.77B	0.84	4.41 million shs	4.24 million shs
TD Toronto-Dominion Bank	C$102.88 +0.4%	C$100.75	C$73.22 ▼ C$103.11	C$180.49B	0.82	7.54 million shs	3.65 million shs

These 7 Stocks Will Be Magnificent in 2025

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
PEP PepsiCo	+0.44%	-0.51%	+2.73%	+15.70%	-14.59%
ABBV AbbVie	+0.35%	+1.76%	+10.48%	+14.59%	+7.00%
CVX Chevron	+1.76%	+0.88%	+3.23%	+15.54%	+8.63%
JNJ Johnson & Johnson	+0.11%	+1.32%	+5.96%	+16.97%	+10.97%
KO CocaCola	-0.74%	+0.23%	+1.36%	-2.40%	+0.74%
PFE Pfizer	+0.46%	+2.64%	+1.98%	+10.68%	-10.99%
PG Procter & Gamble	-0.12%	+2.73%	+0.18%	-4.48%	-6.84%
XOM Exxon Mobil	+1.96%	+4.30%	+1.16%	+7.77%	-2.40%
RY Royal Bank of Canada	+0.65%	+1.14%	+4.51%	+8.27%	+24.15%
TD Toronto-Dominion Bank	+0.42%	+0.52%	+0.43%	+10.73%	+26.56%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
PEP PepsiCo	4.0788 of 5 stars	2.1	3.0	4.2	1.5	2.9	1.7	1.3
ABBV AbbVie	4.7609 of 5 stars	2.5	4.0	3.3	3.9	3.9	2.5	1.3
CVX Chevron	4.7181 of 5 stars	2.2	5.0	4.2	0.0	3.5	1.7	3.1
JNJ Johnson & Johnson	4.8479 of 5 stars	2.3	5.0	4.2	3.9	3.5	1.7	1.9
KO CocaCola	4.8159 of 5 stars	3.5	3.0	4.2	0.8	3.5	2.5	1.9
PFE Pfizer	4.6693 of 5 stars	1.2	3.0	4.2	4.5	3.3	1.7	3.1
PG Procter & Gamble	4.7336 of 5 stars	3.3	3.0	4.2	1.7	3.4	2.5	1.3
XOM Exxon Mobil	4.9009 of 5 stars	3.2	4.0	5.0	0.0	3.4	1.7	3.1
RY Royal Bank of Canada	2.0024 of 5 stars	2.5	0.0	1.7	0.0	2.6	1.7	0.6
TD Toronto-Dominion Bank	1.7793 of 5 stars	2.2	0.0	1.7	0.0	2.0	2.5	0.6

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
PEP PepsiCo	2.16	Hold	$158.73	6.08% Upside
ABBV AbbVie	2.96	Moderate Buy	$214.95	2.22% Upside
CVX Chevron	2.36	Hold	$163.95	3.83% Upside
JNJ Johnson & Johnson	2.65	Moderate Buy	$176.29	-1.57% Downside
KO CocaCola	3.06	Buy	$77.21	10.17% Upside
PFE Pfizer	2.39	Hold	$28.12	8.88% Upside
PG Procter & Gamble	2.68	Moderate Buy	$175.94	11.00% Upside
XOM Exxon Mobil	2.43	Hold	$125.00	12.49% Upside
RY Royal Bank of Canada	3.00	Buy	C$190.54	-0.06% Downside
TD Toronto-Dominion Bank	2.33	Hold	C$96.58	-6.12% Downside

Current Analyst Ratings Breakdown

Latest High Dividend Stocks Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/21/2025	JNJ Johnson & Johnson	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$185.00 ➝ $200.00
8/20/2025	CVX Chevron	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$186.00 ➝ $197.00
8/20/2025	CVX Chevron	Melius Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Hold	$155.00
8/20/2025	CVX Chevron	Melius Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Hold	$155.00
8/20/2025	XOM Exxon Mobil	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$130.00 ➝ $143.00
8/20/2025	XOM Exxon Mobil	Melius Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Hold	$111.00
8/20/2025	XOM Exxon Mobil	Melius Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Hold	$111.00
8/20/2025	RY Royal Bank of Canada	CIBC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform	C$183.00 ➝ C$195.00
8/20/2025	TD Toronto-Dominion Bank	CIBC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform	C$99.00 ➝ C$109.00
8/18/2025	XOM Exxon Mobil	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$134.00 ➝ $145.00
8/18/2025	CVX Chevron	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$164.00 ➝ $168.00

(Data available from 8/23/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
PEP PepsiCo	$91.85B	2.23	$11.03 per share	13.57	$13.56 per share	11.04
ABBV AbbVie	$56.33B	6.59	$14.99 per share	14.03	($0.08) per share	-2,628.55
CVX Chevron	$187.74B	1.45	$20.06 per share	7.87	$85.22 per share	1.85
JNJ Johnson & Johnson	$88.82B	4.86	$13.13 per share	13.64	$32.58 per share	5.50
KO CocaCola	$47.06B	6.41	$3.12 per share	22.48	$7.01 per share	10.00
PFE Pfizer	$63.83B	2.30	$4.38 per share	5.90	$15.66 per share	1.65
PG Procter & Gamble	$84.28B	4.41	$8.36 per share	18.97	$21.99 per share	7.21
XOM Exxon Mobil	$349.59B	1.36	$13.17 per share	8.44	$63.32 per share	1.75
RY Royal Bank of Canada	C$57.52B	4.69	C$799.04 per share	0.24	C$89.94 per share	2.12
TD Toronto-Dominion Bank	C$56.16B	3.21	C$356.36 per share	0.29	C$65.89 per share	1.56

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
PEP PepsiCo	$9.58B	$5.49	27.26	16.93	3.97	8.23%	57.81%	10.63%	10/9/2025 (Estimated)
ABBV AbbVie	$4.28B	$2.10	100.14	15.04	1.35	6.45%	699.66%	13.64%	10/29/2025 (Estimated)
CVX Chevron	$17.66B	$7.77	20.32	12.54	2.31	7.02%	9.90%	5.87%	11/7/2025 (Estimated)
JNJ Johnson & Johnson	$14.07B	$9.35	19.15	16.18	2.28	25.00%	32.49%	13.00%	10/21/2025 (Estimated)
KO CocaCola	$10.63B	$2.82	24.85	21.97	3.68	25.89%	44.91%	12.23%	10/22/2025 (Estimated)
PFE Pfizer	$8.03B	$1.88	13.74	8.52	0.92	16.84%	21.42%	9.12%	11/4/2025 (Estimated)
PG Procter & Gamble	$15.97B	$6.51	24.35	21.60	4.19	18.95%	32.69%	13.49%	10/17/2025 (Estimated)
XOM Exxon Mobil	$33.68B	$7.04	15.78	12.32	2.05	9.17%	11.34%	6.79%	11/7/2025 (Estimated)
RY Royal Bank of Canada	C$16.24B	C$11.48	16.61	∞	3.42	28.23%	13.27%	0.80%	N/A
TD Toronto-Dominion Bank	C$8.88B	C$5.05	20.38	∞	1.22	15.80%	7.84%	0.43%	N/A

Latest High Dividend Stocks Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/5/2025	Q2 2025	PFE Pfizer	$0.58	$0.78	+$0.20	$0.51	$13.43 billion	$14.65 billion
8/1/2025	Q2 2025	CVX Chevron	$1.58	$1.77	+$0.19	$1.45	$44.59 billion	$44.82 billion
8/1/2025	Q2 2025	XOM Exxon Mobil	$1.47	$1.64	+$0.17	$1.64	$79.07 billion	$81.51 billion
7/31/2025	Q2 2025	ABBV AbbVie	$3.24	$2.97	-$0.27	$0.52	$14.93 billion	$15.42 billion
7/29/2025	Q4 2025	PG Procter & Gamble	$1.42	$1.48	+$0.06	$1.48	$20.79 billion	$20.89 billion
7/22/2025	Q2 2025	KO CocaCola	$0.83	$0.87	+$0.04	$0.88	$12.55 billion	$12.50 billion
7/17/2025	Q2 2025	PEP PepsiCo	$2.03	$2.12	+$0.09	$0.92	$22.28 billion	$22.73 billion
7/16/2025	Q2 2025	JNJ Johnson & Johnson	$2.68	$2.77	+$0.09	$2.29	$22.85 billion	$23.74 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
PEP PepsiCo	$5.69	3.80%	N/A	103.64%	54 Years
ABBV AbbVie	$6.56	3.12%	N/A	312.38%	53 Years
CVX Chevron	$6.84	4.33%	N/A	88.03%	38 Years
JNJ Johnson & Johnson	$5.20	2.90%	N/A	55.61%	64 Years
KO CocaCola	$2.04	2.91%	N/A	72.34%	64 Years
PFE Pfizer	$1.72	6.66%	N/A	91.49%	16 Years
PG Procter & Gamble	$4.23	2.67%	N/A	64.98%	70 Years
XOM Exxon Mobil	$3.96	3.56%	N/A	56.25%	42 Years
RY Royal Bank of Canada	C$5.68	2.98%	N/A	49.49%	N/A
TD Toronto-Dominion Bank	C$4.08	3.97%	N/A	80.84%	N/A

Latest High Dividend Stocks Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
7/17/2025	KO CocaCola	quarterly	$0.51	2.89%	9/15/2025	9/15/2025	10/1/2025
7/24/2025	PEP PepsiCo	quarterly	$1.4225	3.94%	9/5/2025	9/5/2025	9/30/2025
8/4/2025	CVX Chevron	quarterly	$1.71	4.6%	8/19/2025	8/19/2025	9/10/2025
8/1/2025	XOM Exxon Mobil	quarterly	$0.99	3.54%	8/15/2025	8/15/2025	9/10/2025
7/16/2025	JNJ Johnson & Johnson	quarterly	$1.30	3.35%	8/26/2025	8/26/2025	9/9/2025
6/25/2025	PFE Pfizer	quarterly	$0.43	7.08%	7/25/2025	7/25/2025	9/2/2025
7/24/2025	RY Royal Bank of Canada	quarterly	C$1.54	3.45%	7/24/2025	8/22/2025	8/22/2025
6/20/2025	ABBV AbbVie	quarterly	$1.64	3.54%	7/15/2025	7/15/2025	8/15/2025
7/8/2025	PG Procter & Gamble	quarterly	$1.0568	2.68%	7/18/2025	7/18/2025	8/15/2025
7/10/2025	TD Toronto-Dominion Bank	quarterly	C$1.05	4.67%	7/10/2025	7/31/2025	7/31/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
PEP PepsiCo	2.12	0.78	0.60
ABBV AbbVie	44.14	0.74	0.61
CVX Chevron	0.16	1.00	0.74
JNJ Johnson & Johnson	0.50	1.01	0.76
KO CocaCola	1.49	1.21	0.98
PFE Pfizer	0.65	1.16	0.85
PG Procter & Gamble	0.49	0.70	0.49
XOM Exxon Mobil	0.12	1.25	0.88
RY Royal Bank of Canada	373.13	N/A	N/A
TD Toronto-Dominion Bank	400.02	N/A	N/A

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
PEP PepsiCo	73.07%
ABBV AbbVie	70.23%
CVX Chevron	72.42%
JNJ Johnson & Johnson	69.55%
KO CocaCola	70.26%
PFE Pfizer	68.36%
PG Procter & Gamble	65.77%
XOM Exxon Mobil	61.80%
RY Royal Bank of Canada	52.50%
TD Toronto-Dominion Bank	58.05%

Insider Ownership

Company	Insider Ownership
PEP PepsiCo	0.14%
ABBV AbbVie	0.25%
CVX Chevron	0.21%
JNJ Johnson & Johnson	0.16%
KO CocaCola	0.97%
PFE Pfizer	0.06%
PG Procter & Gamble	0.18%
XOM Exxon Mobil	0.03%
RY Royal Bank of Canada	N/A
TD Toronto-Dominion Bank	0.08%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
PEP PepsiCo	319,000	1.37 billion	1.37 billion	Optionable
ABBV AbbVie	55,000	1.77 billion	1.76 billion	Optionable
CVX Chevron	45,298	1.73 billion	1.72 billion	Optionable
JNJ Johnson & Johnson	138,100	2.41 billion	2.40 billion	Optionable
KO CocaCola	69,700	4.30 billion	4.26 billion	Optionable
PFE Pfizer	81,000	5.69 billion	5.68 billion	Optionable
PG Procter & Gamble	109,000	2.34 billion	2.34 billion	Optionable
XOM Exxon Mobil	61,000	4.26 billion	4.26 billion	Optionable
RY Royal Bank of Canada	91,400	1.42 billion	N/A	Not Optionable
TD Toronto-Dominion Bank	93,700	1.75 billion	N/A	Not Optionable

High Dividend Stocks Headlines

Recent News About These Companies

Toronto-Dominion Bank News (TD) - Investing.com

August 23 at 6:24 AM | investing.com

These 2 Long-Term Bank Stocks Could Transform Your Portfolio by 2040

August 22 at 9:24 PM | msn.com

Toronto-Dominion Bank stock rises Friday, still underperforms market

August 22 at 9:24 PM | marketwatch.com

CIBC Boosts Toronto-Dominion Bank (TSE:TD) Price Target to C$109.00

August 22 at 2:32 AM | americanbankingnews.com

TSE:TD Q4 EPS Estimate Increased by National Bank Financial

August 19, 2025 | marketbeat.com

Toronto-Dominion Bank (TSE:TD) Stock Price Passes Above 200 Day Moving Average - What's Next?

August 18, 2025 | marketbeat.com

Toronto-Dominion Bank (TSE:TD) Stock Price Expected to Rise, National Bankshares Analyst Says

August 17, 2025 | marketbeat.com

Equities Analysts Issue Forecasts for TSE:TD Q3 Earnings

August 17, 2025 | marketbeat.com

Toronto-Dominion Bank (TSE:TD) Price Target Raised to C$99.00 at National Bankshares

August 17, 2025 | americanbankingnews.com

Barclays Issues Positive Forecast for Toronto-Dominion Bank (TSE:TD) Stock Price

August 16, 2025 | marketbeat.com

Toronto-Dominion Bank (TSE:TD) Sets New 52-Week High Following Analyst Upgrade

August 16, 2025 | marketbeat.com

Desjardins Has Bullish Outlook for TSE:TD FY2025 Earnings

August 16, 2025 | marketbeat.com

Toronto-Dominion Bank (TSE:TD) Reaches New 52-Week High Following Analyst Upgrade

August 16, 2025 | americanbankingnews.com

Equities Analysts Offer Predictions for TSE:TD Q3 Earnings

August 16, 2025 | americanbankingnews.com

Toronto-Dominion Bank (TSE:TD) Price Target Raised to C$117.00 at Jefferies Financial Group

August 15, 2025 | marketbeat.com

Toronto-Dominion Bank (TSE:TD) Rating Increased to Buy at Desjardins

August 15, 2025 | marketbeat.com

Toronto-Dominion Bank (TSE:TD) Price Target Raised to C$95.00

August 15, 2025 | americanbankingnews.com

Toronto-Dominion Bank (TSE:TD) Upgraded to Moderate Buy at Desjardins

August 15, 2025 | americanbankingnews.com

TD Bank Names Chris Ward Head of U.S. Small Business Banking

August 8, 2025 | marketwatch.com

TD Bank Is Quietly up 32% This Year: Should You Sell After the Recent Rise?

August 8, 2025 | msn.com

Toronto-Dominion Bank (TSE:TD) Stock Price Crosses Above Two Hundred Day Moving Average - Here's What Happened

August 8, 2025 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

High Dividend Stocks Company Descriptions

PepsiCo NASDAQ:PEP

$149.64 +0.66 (+0.44%)

Closing price 08/22/2025 04:00 PM Eastern

Extended Trading

$149.78 +0.14 (+0.09%)

As of 08/22/2025 07:59 PM Eastern

PepsiCo, Inc. engages in the manufacture, marketing, distribution, and sale of various beverages and convenient foods worldwide. The company operates through seven segments: Frito-Lay North America; Quaker Foods North America; PepsiCo Beverages North America; Latin America; Europe; Africa, Middle East and South Asia; and Asia Pacific, Australia and New Zealand and China Region. It provides dips, cheese-flavored snacks, and spreads, as well as corn, potato, and tortilla chips; cereals, rice, pasta, mixes and syrups, granola bars, grits, oatmeal, rice cakes, and side dishes; beverage concentrates, fountain syrups, and finished goods; ready-to-drink tea, coffee, and juices; dairy products; and sparkling water makers and related products, as well as distributes alcoholic beverages under Hard MTN Dew brand. The company offers its products primarily under the Lay's, Doritos, Fritos, Tostitos, BaiCaoWei, Cheetos, Cap'n Crunch, Life, Pearl Milling Company, Gatorade, Pepsi-Cola, Mountain Dew, Quaker, Rice-A-Roni, Aquafina, Bubly, Emperador, Diet Mountain Dew, Diet Pepsi, Gatorade Zero, Crush, Propel, Dr Pepper, Schweppes, Marias Gamesa, Ruffles, Sabritas, Saladitas, Tostitos, 7UP, Diet 7UP, H2oh!, Manzanita Sol, Mirinda, Pepsi Black, Pepsi Max, San Carlos, Toddy, Walkers, Chipsy, Kurkure, Sasko, Spekko, White Star, Smith's, Sting, SodaStream, Lubimyj Sad, Agusha, Chudo, Domik v Derevne, Lipton, and other brands. It serves wholesale and other distributors, foodservice customers, grocery stores, drug stores, convenience stores, discount/dollar stores, mass merchandisers, membership stores, hard discounters, e-commerce retailers and authorized independent bottlers, and others through a network of direct-store-delivery, customer warehouse, and distributor networks, as well as directly to consumers through e-commerce platforms and retailers. The company was founded in 1898 and is based in Purchase, New York.

AbbVie NYSE:ABBV

$210.28 +0.78 (+0.37%)

Closing price 08/22/2025 03:59 PM Eastern

Extended Trading

$210.12 -0.17 (-0.08%)

As of 08/22/2025 07:59 PM Eastern

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, ulcerative colitis, and Crohn's disease; Imbruvica for the treatment of adult patients with blood cancers; Epkinly to treat lymphoma; Elahere to treat cancer; and Venclexta/Venclyxto to treat blood cancers. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox therapeutic; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; Ubrelvy for the acute treatment of migraine in adults; and Qulipta for episodic and chronic migraine. In addition, the company offers Ozurdex for eye diseases; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; Restasis to increase tear production; and other eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism. It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; Janssen Biotech, Inc.; and Genentech, Inc., as well as collaboration with Tentarix Biotherapeutics, LP to develop conditionally-active and multi-specific biologics for oncology and immunology. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

Chevron NYSE:CVX

$157.90 +2.35 (+1.51%)

Closing price 08/22/2025 03:59 PM Eastern

Extended Trading

$158.18 +0.28 (+0.18%)

As of 08/22/2025 07:59 PM Eastern

Chevron Corporation, through its subsidiaries, engages in the integrated energy and chemicals operations in the United States and internationally. The company operates in two segments, Upstream and Downstream. The Upstream segment is involved in the exploration, development, production, and transportation of crude oil and natural gas; processing, liquefaction, transportation, and regasification of liquefied natural gas; transportation of crude oil through pipelines; transportation, storage, and marketing of natural gas; and carbon capture and storage, as well as a gas-to-liquids plant. The Downstream segment refines crude oil into petroleum products; markets crude oil, refined products, and lubricants; manufactures and markets renewable fuels, commodity petrochemicals, plastics for industrial uses, and fuel and lubricant additives; and transports crude oil and refined products by pipeline, marine vessel, motor equipment, and rail car. The company was formerly known as ChevronTexaco Corporation and changed its name to Chevron Corporation in 2005. Chevron Corporation was founded in 1879 and is headquartered in San Ramon, California.

Johnson & Johnson NYSE:JNJ

$179.10 +0.17 (+0.09%)

Closing price 08/22/2025 03:59 PM Eastern

Extended Trading

$179.22 +0.12 (+0.07%)

As of 08/22/2025 07:56 PM Eastern

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

CocaCola NYSE:KO

$70.08 -0.58 (-0.82%)

Closing price 08/22/2025 03:59 PM Eastern

Extended Trading

$70.18 +0.09 (+0.13%)

As of 08/22/2025 07:59 PM Eastern

The Coca-Cola Company, a beverage company, manufactures, markets, and sells various nonalcoholic beverages worldwide. The company provides sparkling soft drinks, sparkling flavors; water, sports, coffee, and tea; juice, value-added dairy, and plant-based beverages; and other beverages. It also offers beverage concentrates and syrups, as well as fountain syrups to fountain retailers, such as restaurants and convenience stores. The company sells its products under the Coca-Cola, Diet Coke/Coca-Cola Light, Coca-Cola Zero Sugar, caffeine free Diet Coke, Cherry Coke, Fanta Orange, Fanta Zero Orange, Fanta Zero Sugar, Fanta Apple, Sprite, Sprite Zero Sugar, Simply Orange, Simply Apple, Simply Grapefruit, Fresca, Schweppes, Thums Up, Aquarius, Ayataka, BODYARMOR, Ciel, Costa, Dasani, dogadan, FUZE TEA, Georgia, glacéau smartwater, glacéau vitaminwater, Gold Peak, Ice Dew, I LOHAS, Powerade, Topo Chico, AdeS, Del Valle, fairlife, innocent, Minute Maid, and Minute Maid Pulpy brands. It operates through a network of independent bottling partners, distributors, wholesalers, and retailers, as well as through bottling and distribution operators. The company was founded in 1886 and is headquartered in Atlanta, Georgia.

Pfizer NYSE:PFE

$25.82 +0.09 (+0.33%)

Closing price 08/22/2025 03:59 PM Eastern

Extended Trading

$25.85 +0.03 (+0.10%)

As of 08/22/2025 07:59 PM Eastern

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Procter & Gamble NYSE:PG

$158.51 -0.22 (-0.14%)

Closing price 08/22/2025 03:59 PM Eastern

Extended Trading

$158.65 +0.13 (+0.08%)

As of 08/22/2025 07:55 PM Eastern

Procter & Gamble Co. engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances. The Health Care segment includes oral care products like toothbrushes, toothpaste, and personal health care such as gastrointestinal, rapid diagnostics, respiratory, and vitamins, minerals, and supplements. The Fabric and Home care segment consists of fabric enhancers, laundry additives and detergents, and air, dish, and surface care. The Baby, Feminine and Family Care segment sells baby wipes, diapers, and pants, adult incontinence, feminine care, paper towels, tissues, and toilet paper. The company was founded by William Procter and James Gamble in 1837 and is headquartered in Cincinnati, OH.

Exxon Mobil NYSE:XOM

$111.12 +1.89 (+1.73%)

Closing price 08/22/2025 03:59 PM Eastern

Extended Trading

$111.27 +0.15 (+0.14%)

As of 08/22/2025 07:59 PM Eastern

Exxon Mobil Corporation engages in the exploration and production of crude oil and natural gas in the United States and internationally. It operates through Upstream, Energy Products, Chemical Products, and Specialty Products segments. The Upstream segment explores for and produces crude oil and natural gas. The Energy Products segment offers fuels, aromatics, catalysts, and licensing services. It sells its products under the Exxon, Esso, and Mobil brands. The Chemical Products segment manufactures and markets petrochemicals, including olefins, polyolefins, and intermediates. The Specialty Products segment offers performance products, including lubricants, basestocks, waxes, synthetics, elastomers, and resins. The company is also involved in the manufacturing, trade, transport, and selling crude oil, natural gas, petroleum products, petrochemicals, and other specialty products in pursuit of lower-emission business opportunities, including carbon capture and storage, hydrogen, lower-emission fuels, and lithium. Exxon Mobil Corporation was founded in 1870 and is based in Spring, Texas.

Royal Bank of Canada TSE:RY

C$190.65 +1.24 (+0.65%)

As of 08/22/2025 04:00 PM Eastern

Royal Bank of Canada is one of the two largest banks in Canada. It is a diversified financial services company, offering personal and commercial banking, wealth-management services, insurance, corporate banking, and capital markets services. The bank is concentrated in Canada, with additional operations in the U.S. and other countries.

Toronto-Dominion Bank TSE:TD

C$102.88 +0.43 (+0.42%)

As of 08/22/2025 04:00 PM Eastern

Toronto-Dominion is one of Canada's two largest banks and operates three business segments: Canadian retail banking, U.S. retail banking, and wholesale banking. The bank's U.S. operations span from Maine to Florida, with a strong presence in the Northeast. It also has a 13% ownership stake in Charles Schwab.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare High Dividend Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare MarketRank™

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest High Dividend Stocks Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest High Dividend Stocks Earnings

Compare Dividends

Latest High Dividend Stocks Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

High Dividend Stocks Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

High Dividend Stocks Company Descriptions

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools